DIFFUSION PHARMACEUTICALS IN's ticker is DFFN and the CUSIP is 253748206. A total of 9 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $3,000 | -95.1% | 6,690 | -95.1% | 0.00% | -100.0% |
Q2 2018 | $61,000 | -16.4% | 135,551 | 0.0% | 0.01% | -16.7% |
Q1 2018 | $73,000 | -51.7% | 135,551 | +5.2% | 0.01% | -53.8% |
Q4 2017 | $151,000 | -34.1% | 128,861 | -7.2% | 0.01% | -38.1% |
Q3 2017 | $229,000 | -28.9% | 138,810 | 0.0% | 0.02% | -32.3% |
Q2 2017 | $322,000 | +705.0% | 138,810 | +1295.2% | 0.03% | +675.0% |
Q1 2017 | $40,000 | – | 9,949 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Swift Run Capital | 2,348,017 | $1,014,000 | 0.88% |
Signature Financial Management, Inc. | 12,350 | $5,000 | 0.00% |
Virtu Financial LLC | 41,515 | $18,000 | 0.00% |
Smithfield Trust Co | 2,052 | $1,000 | 0.00% |
VANGUARD GROUP INC | 894,732 | $386,000 | 0.00% |
JOYN Advisors, Inc. | 1,740 | $1,000 | 0.00% |
JANE STREET GROUP, LLC | 18,787 | $8,000 | 0.00% |
St. Johns Investment Management Company, LLC | 23 | $0 | 0.00% |
UBS Group AG | 31,096 | $13,000 | 0.00% |
Advisor Group, Inc. | 4,370 | $2,000 | 0.00% |